PULSE-ELECTRICAL ABLATION IN ATRIAL FIBRILLATION: EFFICACY AND SAFETY ACCORDING TO CURRENT RANDOMIZED TRIALS AND META-ANALYSES 2025–2026
Keywords:
atrial fibrillation; pulsed field ablation; irreversible electroporation; catheter ablation; pulmonary vein isolation; radiofrequency ablation; cryoballoon ablation;Abstract
Atrial fibrillation (AF) is the most common persistent cardiac arrhythmia and is associated with an increased risk of stroke, heart failure, hospitalizations, and cardiovascular mortality. Catheter pulmonary vein isolation (PVI) is central to the current rhythm control strategy in patients with symptomatic AF, especially when antiarrhythmic therapy is ineffective or intolerant. Traditionally, thermal methods have been used to perform PVI, primarily radiofrequency (RF) and cryoballoon ablation. Despite the proven effectiveness of these technologies, their use is associated with the risk of damage to surrounding tissues, including the esophagus, phrenic nerve and coronary arteries.Pulsed field ablation (PFA) is a fundamentally new method of catheter ablation based on the use of short, high-voltage electrical pulses that cause irreversible electroporation of cell membranes. The presumed tissue selectivity of electroporation may provide preferential damage to cardiomyocytes with relative preservation of surrounding structures. This has the potential to reduce the risk of some of the complications associated with thermal ablation while reducing the duration of the procedure.
References
1.Mojica JC, Dandamudi M, Interior J, et al. Efficacy and safety of pulsed field ablation versus conventional thermal techniques for patients with atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. BMC Cardiovascular Disorders. 2026. (Mojica et al., 2026)
2.Reddy VY, Gerstenfeld EP, Mountantonakis SE, et al. Pulsed field ablation versus conventional thermal ablation for paroxysmal atrial fibrillation: 4-year outcomes in the ADVENT-LTO study. Nature Medicine. 2026;32:1444–1453. (Reddy et al., 2026)
3.Kamel O, Sawalha K, Abdelazem M, et al. Outcomes of pulsed field versus cryoballoon ablation in atrial fibrillation: a comprehensive systematic review and meta-analysis. Journal of Arrhythmia. 2026;42. (Kamel et al., 2026)
4.Esteves IM, Pontes VB, Trevisan T, et al. Pulsed-field ablation versus radiofrequency ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis. Journal of Arrhythmia. 2025;41. (Esteves et al., 2025)
5.Badertscher P, du Fay de Lavallaz J, Reichlin T, et al. Pulsed-field ablation vs. thermal ablation for paroxysmal atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Europace. 2025;27. (Badertscher et al., 2025)
6.Prajapati P, Vemulapalli H, Rodriguez-Riascos J, et al. Evaluating pulsed field ablation for atrial fibrillation: a systematic review and meta-analysis of procedural outcomes. Pacing and Clinical Electrophysiology. 2025;49:124–142. (Prajapati et al., 2025)
7.Al-Farabi M, Raharjo S, Saputra PBT, et al. Comparison of pulse field ablation versus cryoballoon ablation in atrial fibrillation: systematic review and meta-analysis on safety and efficacy. Current Medical Research and Opinion. 2025;41:2217–2225. (Al-Farabi et al., 2025)
8.Schutyser W, Ector J, De Potter TD, Vandenberk B. Evaluation of pulsed-field ablation for paroxysmal atrial fibrillation: a systematic review. Acta Cardiologica. 2025;81:128–142. (Schutyser et al., 2025)
9.Malik U, Hashmi TA, Bai P, et al. Pulsed field ablation versus high-power short-duration ablation in atrial fibrillation: a systematic and meta-analysis. Cardiology in Review. 2025. (Malik et al., 2025)
10.Kim HJ, Lee CH. Pulsed field ablation: focused on atrial fibrillation ablation. The Korean Journal of Internal Medicine. 2025;41:197–209. (Kim & Lee, 2025)